Literature DB >> 10757792

Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein.

K Yeung1, P Janosch, B McFerran, D W Rose, H Mischak, J M Sedivy, W Kolch.   

Abstract

We have recently identified the Raf kinase inhibitor protein (RKIP) as a physiological endogenous inhibitor of the Raf-1/MEK/extracellular signal-regulated kinase (ERK) pathway. RKIP interfered with MEK phosphorylation and activation by Raf-1, resulting in the suppression of both Raf-1-induced transformation and AP-1-dependent transcription. Here we report the molecular mechanism of RKIP's inhibitory function. RKIP can form ternary complexes with Raf-1, MEK, and ERK. However, whereas MEK and ERK can simultaneously associate with RKIP, Raf-1 binding to RKIP and that of MEK are mutually exclusive. RKIP is able to dissociate a Raf-1-MEK complex and behaves as a competitive inhibitor of MEK phosphorylation. Mapping of the binding domains showed that MEK and Raf-1 bind to overlapping sites in RKIP, whereas MEK and RKIP associate with different domains in Raf-1, and Raf-1 and RKIP bind to different sites in MEK. Both the Raf-1 and the MEK binding sites in RKIP need to be destroyed in order to relieve RKIP-mediated suppression of the Raf-1/MEK/ERK pathway, indicating that binding of either Raf-1 or MEK is sufficient for inhibition. The properties of RKIP reveal the specific sequestration of interacting components as a novel motif in the cell's repertoire for the regulation of signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10757792      PMCID: PMC85596          DOI: 10.1128/MCB.20.9.3079-3085.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  27 in total

Review 1.  Control of the ERK MAP kinase cascade by Ras and Raf.

Authors:  R Marais; C J Marshall
Journal:  Cancer Surv       Date:  1996

2.  Inhibition of Raf-1 signaling by a monoclonal antibody, which interferes with Raf-1 activation and with Mek substrate binding.

Authors:  W Kolch; A Philipp; H Mischak; E M Dutil; T M Mullen; J R Feramisco; J L Meinkoth; D W Rose
Journal:  Oncogene       Date:  1996-09-19       Impact factor: 9.867

Review 3.  MAP kinases in mitogenesis and development.

Authors:  J E Ferrell
Journal:  Curr Top Dev Biol       Date:  1996       Impact factor: 4.897

Review 4.  KSR: a novel player in the RAS pathway.

Authors:  J Downward
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

5.  Assay and expression of mitogen-activated protein kinase, MAP kinase kinase, and Raf.

Authors:  D R Alessi; P Cohen; A Ashworth; S Cowley; S J Leevers; C J Marshall
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

Review 6.  Three protein kinase structures define a common motif.

Authors:  S S Taylor; E Radzio-Andzelm
Journal:  Structure       Date:  1994-05-15       Impact factor: 5.006

7.  Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP.

Authors:  K Yeung; T Seitz; S Li; P Janosch; B McFerran; C Kaiser; F Fee; K D Katsanakis; D W Rose; H Mischak; J M Sedivy; W Kolch
Journal:  Nature       Date:  1999-09-09       Impact factor: 49.962

8.  Identification of the major phosphorylation sites of the Raf-1 kinase.

Authors:  D K Morrison; G Heidecker; U R Rapp; T D Copeland
Journal:  J Biol Chem       Date:  1993-08-15       Impact factor: 5.157

9.  Mechanism of inhibition of Raf-1 by protein kinase A.

Authors:  S Häfner; H S Adler; H Mischak; P Janosch; G Heidecker; A Wolfman; S Pippig; M Lohse; M Ueffing; W Kolch
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

10.  A proline-rich sequence unique to MEK1 and MEK2 is required for raf binding and regulates MEK function.

Authors:  A D Catling; H J Schaeffer; C W Reuter; G R Reddy; M J Weber
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

View more
  122 in total

1.  Dissection of Ras-dependent signaling pathways controlling aggressive tumor growth of human fibrosarcoma cells: evidence for a potential novel pathway.

Authors:  S Gupta; R Plattner; C J Der; E J Stanbridge
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 2.  Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions.

Authors:  W Kolch
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

3.  PEBP4 gene expression and its significance in invasion and metastasis of non-small cell lung cancer.

Authors:  Gui-Ping Yu; Bin Huang; Guo-Qiang Chen; Song Wu; Yong Ji; Zhen-Ya Shen
Journal:  Tumour Biol       Date:  2011-11-12

4.  Mutant human cells with constitutive activation of NF-kappaB.

Authors:  Swati S Sathe; Nywana Sizemore; Xiaoxia Li; Kalpa Vithalani; Mairead Commane; Shannon M Swiatkowski; George R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

5.  Didymin induces apoptosis by inhibiting N-Myc and upregulating RKIP in neuroblastoma.

Authors:  Jyotsana Singhal; Lokesh Dalasanur Nagaprashantha; Rit Vatsyayan; Sanjay Awasthi; Sharad S Singhal
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-15

Review 6.  Mechanistic principles of RAF kinase signaling.

Authors:  Christian M Udell; Thanashan Rajakulendran; Frank Sicheri; Marc Therrien
Journal:  Cell Mol Life Sci       Date:  2010-09-06       Impact factor: 9.261

Review 7.  What signals are generated by anti-CD20 antibody therapy?

Authors:  Benjamin Bonavida
Journal:  Curr Hematol Malig Rep       Date:  2006-12       Impact factor: 3.952

8.  Expression of RKIP, E-cadherin and NF-kB p65 in esophageal squamous cell carcinoma and their correlations.

Authors:  Fu-Min Ping; Gui-Jing Liu; Zhi-Jun Liu; Hai-Bin Li; Jian-Wen Zhai; Shu-Xia Li; Yue-Mei Liu; Bao-Wei Li; Hong Wei
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  Inverse association between Bmi-1 and RKIP affecting clinical outcome of gastric cancer and revealing the potential molecular mechanisms underlying tumor metastasis and chemotherapy resistance.

Authors:  Yinting Chen; Guoda Lian; Guangsheng Ou; Kege Yang; Jianning Chen; Haigang Li; Shaojie Chen; Jiajia Li; Linjuan Zeng; Kaihong Huang
Journal:  Gastric Cancer       Date:  2015-03-13       Impact factor: 7.370

10.  NF-kappaB1 p105 negatively regulates TPL-2 MEK kinase activity.

Authors:  S Beinke; J Deka; V Lang; M P Belich; P A Walker; S Howell; S J Smerdon; S J Gamblin; S C Ley
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.